Scientific Publications Search Search Author Impact Factor Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Hinz, Michael Dr. (1) Mathas, Stephan Dr. (3) Nguyen, Tam Hoai Dr. (1) Pezzutto, Antonio Prof. Dr. (1) Scheidereit, Claus Prof. Dr. (1) Selbach, Matthias Prof. Dr. (3) Stein, Ulrike Prof. Dr. (2) Uckert, Wolfgang Prof. Dr. (5) Walther, Wolfgang Prof. Dr. (3) (-) Blankenstein, Thomas Prof. Dr. (24) (-) Janz, Martin Dr. (5) (-) Kammertöns, Thomas Dr. (4) 1992 (4) (-) 1993 (7) 1994 (5) 1995 (8) 1996 (6) 1997 (9) 1998 (9) 1999 (3) 2000 (10) 2001 (5) 2002 (5) (-) 2003 (12) (-) 2004 (11) 2005 (12) 2006 (5) 2007 (8) 2008 (7) 2009 (6) 2010 (8) 2011 (9) 2012 (8) 2013 (13) 2014 (5) 2015 (6) 2016 (5) 2017 (9) 2018 (5) 2019 (7) 2020 (7) 2021 (9) 2022 (10) 2023 (10) 2024 (3) (-) Biology of Malignant Lymphomas (5) Molecular Cardiovascular Research (1) (-) Molecular Immunology and Gene Therapy (25) Translational Oncology of Solid Tumors (55) 30 Results: Active Filter: Blankenstein, Thomas Prof. Dr.Janz, Martin Dr.Kammertöns, Thomas Dr.Biology of Malignant LymphomasMolecular Immunology and Gene Therapy199320032004 Sort: Result score Newest to oldest Oldest to newest January 01, 2003 / J Biol Chem YB-1 as a cell cycle-regulated transcription factor facilitating cyclin A and cyclin B1 gene expression K. Juerchott S. Bergmann U. Stein W. Walther M. Janz I. Manni G. Piaggio E. Fietze M. Dietel H.D. Royer August 01, 2003 / Blood Inhibition of NF-κB essentially contributes to arsenic-induced apoptosis S. Mathas A. Lietz M. Janz M. Hinz F. Jundt C. Scheidereit K. Bommert B. Doerken January 01, 2003 / Canc Res A critical requirement of interferon gamma-mediated angiostasis for tumor rejection by CD8T cells Z.H. Qin J. Schwartzkopff F. Pradera T. Kammertoens B. Seliger H. Pircher T. Blankenstein August 10, 2003 / Hum Gene Ther Retroviral vectors for high-level transgene expression in T lymphocytes B. Engels H. Cam T. Schueler S. Indraccolo M. Gladow C. Baum T. Blankenstein W. Uckert November 17, 2003 / J Exp Med Tumor rejection by modulation of tumor stromal fibroblasts T. Schueler S. Koernig T. Blankenstein January 01, 2004 / Nat Immunol A cancer immunosurveillance controversy Z.H. Qin T. Blankenstein December 01, 2003 / J Mol Med Transduction efficiency of MLV but not of HIV-1 vectors is pseudotype dependent on human primary T lymphocytes M.D. Muehlebach I. Schmitt S. Steidl J. Stitz M. Schweizer T. Blankenstein K. Cichutek W. Uckert January 01, 2003 / Adv Cancer Res Chemical carcinogens as foreign bodies and some pitfalls regarding cancer immune surveillance T. Blankenstein Z. Qin January 30, 2003 / Oncogene Overexpression of NPM-ALK induces different types of malignant lymphomas in IL-9 transgenic mice K. Lange W. Uckert T. Blankenstein R. Nadrowitz C. Bittner J.C. Renauld J. van Snick A.C. Feller H. Merz April 01, 2003 / Curr Opin Immunol The role of IFN-gamma in tumor transplantation immunity and inhibition of chemical carcinogenesis T. Blankenstein Z.H. Qin Pagination Current page 1 Page 2 Page 3 Next page Next › Last page Last »
January 01, 2003 / J Biol Chem YB-1 as a cell cycle-regulated transcription factor facilitating cyclin A and cyclin B1 gene expression K. Juerchott S. Bergmann U. Stein W. Walther M. Janz I. Manni G. Piaggio E. Fietze M. Dietel H.D. Royer
August 01, 2003 / Blood Inhibition of NF-κB essentially contributes to arsenic-induced apoptosis S. Mathas A. Lietz M. Janz M. Hinz F. Jundt C. Scheidereit K. Bommert B. Doerken
January 01, 2003 / Canc Res A critical requirement of interferon gamma-mediated angiostasis for tumor rejection by CD8T cells Z.H. Qin J. Schwartzkopff F. Pradera T. Kammertoens B. Seliger H. Pircher T. Blankenstein
August 10, 2003 / Hum Gene Ther Retroviral vectors for high-level transgene expression in T lymphocytes B. Engels H. Cam T. Schueler S. Indraccolo M. Gladow C. Baum T. Blankenstein W. Uckert
November 17, 2003 / J Exp Med Tumor rejection by modulation of tumor stromal fibroblasts T. Schueler S. Koernig T. Blankenstein
December 01, 2003 / J Mol Med Transduction efficiency of MLV but not of HIV-1 vectors is pseudotype dependent on human primary T lymphocytes M.D. Muehlebach I. Schmitt S. Steidl J. Stitz M. Schweizer T. Blankenstein K. Cichutek W. Uckert
January 01, 2003 / Adv Cancer Res Chemical carcinogens as foreign bodies and some pitfalls regarding cancer immune surveillance T. Blankenstein Z. Qin
January 30, 2003 / Oncogene Overexpression of NPM-ALK induces different types of malignant lymphomas in IL-9 transgenic mice K. Lange W. Uckert T. Blankenstein R. Nadrowitz C. Bittner J.C. Renauld J. van Snick A.C. Feller H. Merz
April 01, 2003 / Curr Opin Immunol The role of IFN-gamma in tumor transplantation immunity and inhibition of chemical carcinogenesis T. Blankenstein Z.H. Qin